Apyx Medical Corporation APYX

Company Overview

Apyx Medical Corporation (NASDAQ: APYX) is a medical technology company focused on advanced energy systems used in cosmetic and surgical procedures. The company operates primarily in the aesthetics and surgical markets through its proprietary helium plasma technology platform marketed under the Renuvion brand. Apyx develops and commercializes devices that are used by plastic surgeons, dermatologists, and other medical specialists for soft tissue coagulation, contraction, and ablation procedures. Its operations are concentrated in the medical device industry, particularly minimally invasive cosmetic and surgical technologies.

The company’s primary revenue drivers are the sale of capital equipment, disposable handpieces, and related accessories associated with the Advanced Energy segment. Apyx also maintains an OEM segment that manufactures electrosurgical generators and related products for third-party medical device companies. The company traces its origins to Bovie Medical Corporation, founded in 1979, and later rebranded as Apyx Medical Corporation in 2019 to reflect its strategic emphasis on helium plasma technology and aesthetic surgery applications. Its market positioning is supported by proprietary technology, regulatory clearances in selected indications, and relationships with cosmetic and reconstructive surgeons.